Finally, we also compared the response of mice to LXR agonist treatment during HFD-induced obesity with the expectation that after attenuation of adipose tissue inflammation the phenotype of mice carrying or not TG2 in their bone marrow-derived cells will be similar. The gene discussed is TGM2; the disease is obesity disorder.